Tivity Health (NASDAQ:TVTY) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a report released on Thursday.

Several other equities analysts have also weighed in on the company. Zacks Investment Research upgraded Tivity Health from a “sell” rating to a “hold” rating in a research note on Wednesday, September 6th. SunTrust Banks set a $50.00 price target on Tivity Health and gave the company a “buy” rating in a research note on Friday, October 27th. Chardan Capital restated a “neutral” rating and issued a $44.00 price target (up previously from $40.00) on shares of Tivity Health in a research note on Friday, October 27th. Cantor Fitzgerald restated a “buy” rating and issued a $45.00 price target on shares of Tivity Health in a research note on Monday, November 6th. Finally, Oppenheimer lifted their price target on Tivity Health from $47.00 to $50.00 and gave the company an “outperform” rating in a research note on Wednesday, November 1st. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Tivity Health has an average rating of “Buy” and a consensus target price of $46.25.

Tivity Health (NASDAQ TVTY) opened at $36.35 on Thursday. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.02. Tivity Health has a 52 week low of $20.60 and a 52 week high of $48.50. The firm has a market capitalization of $1,442.06, a PE ratio of 24.56, a P/E/G ratio of 1.94 and a beta of 0.18.

Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.10. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. The firm had revenue of $137.70 million during the quarter, compared to analyst estimates of $137.95 million. The business’s quarterly revenue was up 10.2% on a year-over-year basis. research analysts forecast that Tivity Health will post 1.6 earnings per share for the current year.

In other news, CAO Glenn Hargreaves sold 5,805 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $45.15, for a total transaction of $262,095.75. Following the transaction, the chief accounting officer now directly owns 44,448 shares in the company, valued at approximately $2,006,827.20. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Conan Laughlin sold 490,000 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $34.34, for a total value of $16,826,600.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 875,892 shares of company stock worth $31,815,642. 8.42% of the stock is currently owned by insiders.

Several institutional investors have recently modified their holdings of TVTY. Flinton Capital Management LLC boosted its holdings in shares of Tivity Health by 63.5% during the 2nd quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after purchasing an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC boosted its holdings in shares of Tivity Health by 69.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after purchasing an additional 1,464 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Tivity Health during the 3rd quarter worth approximately $210,000. Crossmark Global Holdings Inc. acquired a new position in shares of Tivity Health during the 3rd quarter worth approximately $279,000. Finally, Piedmont Investment Advisors LLC acquired a new position in shares of Tivity Health during the 2nd quarter worth approximately $290,000.

TRADEMARK VIOLATION WARNING: “BidaskClub Downgrades Tivity Health (TVTY) to Hold” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/bidaskclub-downgrades-tivity-health-tvty-to-hold/1797087.html.

Tivity Health Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with Analyst Ratings Network's FREE daily email newsletter.